Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer/Warner Pro Forma Accounting Shows 1.5% Margin Benefit From Lipitor

Executive Summary

Pfizer/Warner-Lambert's pro forma operating margins will be 1.5 percentage points closer to the Pfizer level after the elimination of double-counting of Lipitor sales.

You may also be interested in...



Pfizer/Pharmacia Merger Review: Firms Expect Second-Request From FTC

The Federal Trade Commission review of the Pfizer/Pharmacia merger should progress relatively smoothly because the same FTC reviewers worked with Pfizer on the Warner-Lambert deal, CEO Hank McKinnell told the Bear Stearns healthcare conference in New York City Sept. 17

Pharmacia To Launch Parecoxib With Zyvox Sales Force: No Partner Needed

Pharmacia plans to launch the injectable COX-2 inhibitor parecoxib using the hospital sales force that launched the antibiotic Zyvox (linezolid), Global Business Management President Carrie Cox said during an Oct. 30 earnings conference call.

Pharmacia To Launch Parecoxib With Zyvox Sales Force: No Partner Needed

Pharmacia plans to launch the injectable COX-2 inhibitor parecoxib using the hospital sales force that launched the antibiotic Zyvox (linezolid), Global Business Management President Carrie Cox said during an Oct. 30 earnings conference call.

Related Content

UsernamePublicRestriction

Register

PS035764

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel